Novavax (NVAX) Stock Up 8% as FDA Approves Updated Covid Vaccine
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreThe price of Bitcoin is struggling to maintain momentum and has succumbed to several macroeconomic factors over the last week. ...
Read moreCovid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out. Makers ...
Read moreAffected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. ...
Read moreChina funeral facilitator Fu Shou Yuan saw its shares recently rally to 7.04 Hong Kong dollars after being down 40%. The ...
Read moreThe Chinese smartphone giant started to let go of some of its staff due to lower sales amid the lockdowns ...
Read moreUS stocks are seeing a lower close to begin the thanksgiving holiday season, with all three major indexes slipping up. The holiday ...
Read moreGoldman Sachs says that it cut its oil forecast by $10 due to some macroeconomic factors regarding China and Russia. ...
Read moreChina experienced abnormal logistics and delivery services due to COVID-19 protocols which led to major drop in sales for Alibaba ...
Read moreFoxconn’s major production base in central China, with around 200,000 employees, is currently not operating.iPhone assembler and Apple (NASDAQ: AAPL) ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential...
The price of Bitcoin is struggling to maintain momentum and has succumbed to several macroeconomic factors over the last week....
Covid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out. Makers...
Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report....
China funeral facilitator Fu Shou Yuan saw its shares recently rally to 7.04 Hong Kong dollars after being down 40%. The...
© 2018 JNews by Jegtheme.